"A":
HS code: 30
Country | |
Direction | |
Country | |
Period | |
Selection products |
Period | Total |
---|---|
2013 | --- |
2014 | --- |
2015 | --- |
2016 | --- |
2017 | --- |
2018 | --- |
2019 | $11 |
2020 | --- |
Total: | $11 |
Group product | 2013 | 2020 | Ch. | ∑ (2013-2020) | Ratio |
---|---|---|---|---|---|
06 3001: Glands and other organs for organo-therapeutic uses | --- | --- | --- | --- | 0% |
06 3002: Human blood; animal blood; vaccines, toxins, cultures of micro-organisms and similar products | --- | --- | --- | $11 | 100% |
06 3003: Medicaments consisting of two or more constituents, for retail sale | --- | --- | --- | --- | 0% |
06 3004: Medicaments consisting of mixed or unmixed products for retail sale | --- | --- | --- | --- | 0% |
06 3005: Wadding, gauze, bandages and similar articles | --- | --- | --- | --- | 0% |
06 3006: Pharmaceutical goods specified in note 4 to this chapter | --- | --- | --- | --- | 0% |
Total: | --- | --- | $11 |
№ | Country | ∑ (2013-2020) | Ratio |
---|---|---|---|
1 | Germany | $17.9 B | 19.8% |
2 | France | $7.31 B | 8.1% |
3 | United States | $5.58 B | 6.2% |
4 | Italy | $5.55 B | 6.1% |
5 | Switzerland | $4.97 B | 5.5% |
6 | India | $4.47 B | 4.9% |
7 | United Kingdom | $3.99 B | 4.4% |
8 | Hungary | $3.41 B | 3.8% |
9 | Netherlands | $3.31 B | 3.7% |
10 | Slovenia | $3.11 B | 3.4% |
11 | Ireland | $3.03 B | 3.3% |
12 | Austria | $2.47 B | 2.7% |
13 | Spain | $1.97 B | 2.2% |
14 | Belgium | $1.9 B | 2.1% |
15 | Belarus | $1.61 B | 1.8% |
... | ... | ... | ... |
166 | Venezuela | $616 | 0% |
167 | El Salvador | $127 | 0% |
168 | Luxembourg | $11 | 0% |
169 | French Guiana | $11 | 0% |
... | ... | ... | ... |
The total for all countries: | $90.5 B | 100% |
№ | Region | ∑ (2013-2020) | Ratio |
---|---|---|---|
1 | Sankt-Peterburg | $60 K | 98.9% |
2 | Tomskaya oblast | $686 | 1.1% |
3 | Moskva | $11 | 0% |
By all regions: | $60.7 K | 100% |